{"id":50376,"date":"2021-06-03T11:35:22","date_gmt":"2021-06-03T10:35:22","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=50376"},"modified":"2021-06-03T11:36:01","modified_gmt":"2021-06-03T10:36:01","slug":"indias-challenges-with-covid-19-vaccination","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/","title":{"rendered":"India&#8217;s challenges with covid-19 vaccination\u00a0"},"content":{"rendered":"<p><span style=\"font-weight: 400\">At the start of 2021, India launched the world&#8217;s largest vaccination drive against covid-19 across 3006 vaccination sites in the country. During the<\/span> <span style=\"font-weight: 400\">initial phase, the plan was to vaccinate 300 million people across cities and rural areas. [<\/span><span style=\"font-weight: 400\">1] <\/span><span style=\"font-weight: 400\">Of the <\/span><span style=\"font-weight: 400\">267 covid-19<\/span> <span style=\"font-weight: 400\">vaccine candidates at different stages of development<\/span><span style=\"font-weight: 400\"> (83 in<\/span> <span style=\"font-weight: 400\">clinical development and 184 in preclinical development) and tested at breakneck speed, eight are scheduled to be manufactured in India alone. [2] Two of these are developed solely in India. With the approval from the Drugs Controller General of India<\/span> <span style=\"font-weight: 400\">under an emergency authorisation<\/span><span style=\"font-weight: 400\">, two coronavirus vaccines<\/span><span style=\"font-weight: 400\">\u2014the <\/span><span style=\"font-weight: 400\">Oxford\/Astra-Zeneca vaccine (Covishield, the Indian version of the AZD1222 vaccine), and the Covaxin, BBV152, developed by a domestic manufacturer Bharat Biotech<\/span><span style=\"font-weight: 400\">\u2014<\/span><span style=\"font-weight: 400\">are currently been used under an emergency authorization. [3]\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">However, the greatest challenge at the moment lies in the logistics of dispensing the vaccine<\/span> <span style=\"font-weight: 400\">to the vast population, a task that is extraordinarily difficult to accomplish. With just about 30,000 cold storage facilities<\/span><span style=\"font-weight: 400\"> scattered across the country, the numbers don\u2019t add up. [4] <\/span><span style=\"font-weight: 400\">Anticipating these challenges, the Indian administration launched the <\/span><span style=\"font-weight: 400\">Electronic Vaccine Intelligence Network<\/span><span style=\"font-weight: 400\">,<\/span><span style=\"font-weight: 400\"> a digital platform to manage its entire vaccine stock, logistics, and cold chain tracking of all the country&#8217;s vaccine storage levels. [5] The National Cold Chain and Vaccine Management Resource Centre has been set up to monitor the process. Placed under the National Institute of Health and Family Welfare, this government agency provides technical support for the immunisation supply chain. Managing vaccine stocks at thousands of local inventories and health centres is enormously challenging.<\/span><span style=\"font-weight: 400\"> In a country that is often plagued by power cuts and transmission faults, the stakes are higher than ever. T<\/span><span style=\"font-weight: 400\">he government of India and state owned public sector organisations <\/span><span style=\"font-weight: 400\">are<\/span><span style=\"font-weight: 400\"> partnering with private companies to cover all eventualities. Customised refrigerators are being manufactured to meet the demand for covid-19 vaccine storage locally. These fridges can hold temperatures<\/span> <span style=\"font-weight: 400\">at 2-8\u00b0C for several days in the event of a power outage.<\/span><\/p>\n<p><span style=\"font-weight: 400\">India&#8217;s immunisation scheme covers childhood vaccinations and has a reputation for running one of the world&#8217;s most successful vaccination programmes, <\/span><span style=\"font-weight: 400\">catering to the needs of more than 26 million newborns and 29 million pregnant women<\/span><span style=\"font-weight: 400\">. [6] However, an adult vaccination drive of this magnitude is an altogether new experience. Accomplishing this mission entails enormous challenges, specifically in reaching out to populations in remote areas. <\/span><span style=\"font-weight: 400\">The task force assigned to<\/span> <span style=\"font-weight: 400\">the vaccine distribution network has to vaccinate nearly 1.4 billion people spread out over<\/span> <span style=\"font-weight: 400\">cities, districts, and villages.\u00a0 Administering an average of 3.4 million vaccine doses per day across a country comprising 28 states and eight union territories presents new challenges. During the initial phase, <\/span><span style=\"font-weight: 400\">t<\/span><span style=\"font-weight: 400\">he National Expert Group on Vaccine Administration for covid-19 <\/span><span style=\"font-weight: 400\">prioritised healthcare and frontline workers; in the second phase, this has been expanded to include people older than 60 years and those aged between 45-59 years who have comorbidities. [<\/span><span style=\"font-weight: 400\">7]<\/span><span style=\"font-weight: 400\">\u00a0<\/span><span style=\"font-weight: 400\">With the government&#8217;s launch of the covid-19 vaccine self-registration portal, participation has increased. Since March 2021, the government has also allowed the private sector to join in its vaccination drive to speed up this process. However, complete vaccination (both doses) has so far been achieved in only <\/span><span style=\"font-weight: 400\">3.1<\/span><span style=\"font-weight: 400\">% of the total population. [<\/span><span style=\"font-weight: 400\">8]<\/span><span style=\"font-weight: 400\">\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Although both of the vaccines currently used in India have been approved, an a<\/span><span style=\"font-weight: 400\">dverse event following immunisation task force was set up to deal with any post-vaccine complications. Despite this initiative, vaccine hesitancy is still hampering full participation. According to the World Health Organization, the three <\/span><span style=\"font-weight: 400\">key reasons for vaccine hesitancy are a lack of confidence (in the vaccine itself or in the healthcare system), complacency, and difficulties in obtaining the vaccine (logistics). [<\/span><span style=\"font-weight: 400\">9] <\/span><span style=\"font-weight: 400\">Some of these concerns are understandable, given the fact that both the covid-19 vaccines were approved under an emergency authorisation without completing the full phase 3 trial<\/span><span style=\"font-weight: 400\">.<\/span><span style=\"font-weight: 400\"> For a socially, linguistically, religiously, and culturally diverse country such as India, the reasons for vaccine hesitancy do not always lie in health concerns, but are deep-rooted in the cultural fabric of its citizen&#8217;s lives. Allegations about animal products, like gelatin, in the vaccines may affect compliance because they<\/span> <span style=\"font-weight: 400\">may clash with the beliefs of<\/span> <span style=\"font-weight: 400\">some communities. [<\/span><span style=\"font-weight: 400\">10]<\/span><span style=\"font-weight: 400\">\u00a0India&#8217;s biggest challenge is to mobilise the population to attend the inoculation sites.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">As for now, it seems that the challenges with the &#8220;known knowns&#8221; (covid cases, hospitalisation, and effective management) are being dealt with, and India is transitioning through the &#8220;known unknowns&#8221; (managing vaccine logistics and unforeseen complications). The real test will lie in dealing with the &#8220;unknown unknowns&#8221; (short-term and long-term vaccine efficacy, capacity to control the pandemic, and boosting the economy and healthcare).<\/span><\/p>\n<p><span style=\"font-weight: 400\">For India, unprecedented challenges of this nature are nothing new. With the emergence of new SARS-CoV-2 variants, India is experiencing a second covid wave. This makes it imperative to vaccinate its citizens faster to prevent further disaster. India is currently managing the challenges of rising covid-19 cases, and a high number of hospitalisations as well as managing vaccine logistics. A further test will lie in dealing with short-term and long-term vaccine efficacy, long term capacity to control the pandemic, and restarting the economy and healthcare. Although uncertainties remain in how to deal with new viral variants, giving hope to the population is as essential as injecting the vaccine itself.\u00a0<\/span><\/p>\n<p><em><strong>Ruby Dhar<\/strong><span style=\"font-weight: 400\">, <\/span><span style=\"font-weight: 400\">Scientist, All India Institute of Medical Sciences, New Delhi, India<\/span><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Babban Jee<\/strong>, Scientist, Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi, India<\/span><\/em><\/p>\n<p><em><span style=\"font-weight: 400\"><strong>Subhradip Karmakar<\/strong>, Associate Professor and Team Leader, All India Institute of Medical Sciences, New Delhi, India<\/span><\/em><\/p>\n<p><em><b>Conflict of interest<\/b><span style=\"font-weight: 400\">: None<\/span><\/em><\/p>\n<p><b>References :<\/b><\/p>\n<ol>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">India plans to vaccinate 300 million people against Covid-19. That&#8217;s almost the size of the US population\u00a0 <\/span><a href=\"https:\/\/edition.cnn.com\/2020\/12\/18\/asia\/india-coronavirus-vaccine-intl-hnk\/index.html\"><span style=\"font-weight: 400\">https:\/\/edition.cnn.com\/2020\/12\/18\/asia\/india-coronavirus-vaccine-intl-hnk\/index.html<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Tracking COVID-19 Vaccines Around the World <\/span><a href=\"https:\/\/www.visualcapitalist.com\/tracking-covid-19-vaccines-around-the-world\/\"><span style=\"font-weight: 400\">https:\/\/www.visualcapitalist.com\/tracking-covid-19-vaccines-around-the-world\/<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">DCGI approves two Covid-19 vaccines for emergency use <\/span><a href=\"https:\/\/www.thehindubusinessline.com\/news\/indian-drug-regulator-approves-covid-19-vaccines-of-astrazeneca-bharat-biotech\/article33485512.ece\"><span style=\"font-weight: 400\">https:\/\/www.thehindubusinessline.com\/news\/indian-drug-regulator-approves-covid-19-vaccines-of-astrazeneca-bharat-biotech\/article33485512.ece<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">With 29,000 cold chains, India readying for Covid vaccination: Health Secretary <\/span><a style=\"background-color: #ffffff;font-size: 1rem\" href=\"https:\/\/www.thehindubusinessline.com\/news\/with-29000-cold-chains-india-readying-for-covid-vaccination-health-secretary\/article33339606.ece\">https:\/\/www.thehindubusinessline.com\/news\/with-29000-cold-chains-india-readying-for-covid-vaccination-health-secretary\/article33339606.ece<\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Information of Electronic Vaccine Intelligence Network (eVIN) <\/span><a href=\"https:\/\/indianexpress.com\/article\/explained\/what-is-evin-and-how-will-it-be-used-for-distributing-covid-19-vaccine-7065083\/\"><span style=\"font-weight: 400\">https:\/\/covid19.india.gov.in\/document\/information-of-electronic-vaccine-intelligence-network-evin\/\/<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">National Health Mission. <\/span><a href=\"https:\/\/nhm.gov.in\/index1.php?lang=1&amp;level=2&amp;sublinkid=824&amp;lid=220\"><span style=\"font-weight: 400\">https:\/\/nhm.gov.in\/index1.php?lang=1&amp;level=2&amp;sublinkid=824&amp;lid=220<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Government opens COVID-19 shots for all above 45, says it has enough stock of vaccines <\/span><a href=\"https:\/\/www.livemint.com\/news\/india\/india-opens-vaccination-for-all-above-45-yrs-of-age-irrespective-of-comorbidity-11616514379667.html\"><span style=\"font-weight: 400\">https:\/\/www.livemint.com\/news\/india\/india-opens-vaccination-for-all-above-45-yrs-of-age-irrespective-of-comorbidity-11616514379667.html<\/span><\/a><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">National Co-Win statistics https:\/\/dashboard.cowin.gov.in\/ . Last accessed 29.05.2021<\/span><\/li>\n<li style=\"font-weight: 400\">Report of the SAGE working group on vaccine hesitancy. <span style=\"font-weight: 400\">https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf<\/span><\/li>\n<li style=\"font-weight: 400\">Faith or safety? Covid vaccines spark religious concerns over pork gelatin, cow blood <a style=\"background-color: #ffffff;font-size: 1rem\" href=\"https:\/\/www.indiatoday.in\/coronavirus-outbreak\/vaccine-updates\/story\/religious-hurdle-for-covid-19-vaccines-religious-leaders-raise-concern-over-pork-gelatin-cow-blood-in-vaccines-1753992-2020-12-28\">https:\/\/www.indiatoday.in\/coronavirus-outbreak\/vaccine-updates\/story\/religious-hurdle-for-covid-19-vaccines-religious-leaders-raise-concern-over-pork-gelatin-cow-blood-in-vaccines-1753992-2020-12-28<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>At the start of 2021, India launched the world&#8217;s largest vaccination drive against covid-19 across 3006 vaccination sites in the country. During the initial phase, the plan was to vaccinate [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":66,"featured_media":50378,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[447],"tags":[],"class_list":["post-50376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-india"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>India&#039;s challenges with covid-19 vaccination\u00a0 - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"India&#039;s challenges with covid-19 vaccination\u00a0 - The BMJ\" \/>\n<meta property=\"og:description\" content=\"At the start of 2021, India launched the world&#8217;s largest vaccination drive against covid-19 across 3006 vaccination sites in the country. During the initial phase, the plan was to vaccinate [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-03T10:35:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-03T10:36:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/06\/india_covid_19_vaccine_PA-57654554.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"540\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"julietwalker\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"julietwalker\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/\"},\"author\":{\"name\":\"julietwalker\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/373707d32533c2cbca204980b8cd3493\"},\"headline\":\"India&#8217;s challenges with covid-19 vaccination\u00a0\",\"datePublished\":\"2021-06-03T10:35:22+00:00\",\"dateModified\":\"2021-06-03T10:36:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/\"},\"wordCount\":1109,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/06\\\/india_covid_19_vaccine_PA-57654554.jpg\",\"articleSection\":[\"South Asia\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/\",\"name\":\"India's challenges with covid-19 vaccination\u00a0 - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/06\\\/india_covid_19_vaccine_PA-57654554.jpg\",\"datePublished\":\"2021-06-03T10:35:22+00:00\",\"dateModified\":\"2021-06-03T10:36:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/06\\\/india_covid_19_vaccine_PA-57654554.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2021\\\/06\\\/india_covid_19_vaccine_PA-57654554.jpg\",\"width\":540,\"height\":350,\"caption\":\"A worker carries a package of Oxford-Astrazeneca COVID-19 vaccines that arrived from India as a gift to Bangladesh, in Dhaka, Bangladesh January 21, 2021. REUTERS\\\/Mohammad Ponir Hossain\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2021\\\/06\\\/03\\\/indias-challenges-with-covid-19-vaccination\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"India&#8217;s challenges with covid-19 vaccination\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/373707d32533c2cbca204980b8cd3493\",\"name\":\"julietwalker\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g\",\"caption\":\"julietwalker\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/julietwalker\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"India's challenges with covid-19 vaccination\u00a0 - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/","og_locale":"en_US","og_type":"article","og_title":"India's challenges with covid-19 vaccination\u00a0 - The BMJ","og_description":"At the start of 2021, India launched the world&#8217;s largest vaccination drive against covid-19 across 3006 vaccination sites in the country. During the initial phase, the plan was to vaccinate [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2021-06-03T10:35:22+00:00","article_modified_time":"2021-06-03T10:36:01+00:00","og_image":[{"width":540,"height":350,"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/06\/india_covid_19_vaccine_PA-57654554.jpg","type":"image\/jpeg"}],"author":"julietwalker","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"julietwalker","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/"},"author":{"name":"julietwalker","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/373707d32533c2cbca204980b8cd3493"},"headline":"India&#8217;s challenges with covid-19 vaccination\u00a0","datePublished":"2021-06-03T10:35:22+00:00","dateModified":"2021-06-03T10:36:01+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/"},"wordCount":1109,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/06\/india_covid_19_vaccine_PA-57654554.jpg","articleSection":["South Asia"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/","url":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/","name":"India's challenges with covid-19 vaccination\u00a0 - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/06\/india_covid_19_vaccine_PA-57654554.jpg","datePublished":"2021-06-03T10:35:22+00:00","dateModified":"2021-06-03T10:36:01+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/06\/india_covid_19_vaccine_PA-57654554.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2021\/06\/india_covid_19_vaccine_PA-57654554.jpg","width":540,"height":350,"caption":"A worker carries a package of Oxford-Astrazeneca COVID-19 vaccines that arrived from India as a gift to Bangladesh, in Dhaka, Bangladesh January 21, 2021. REUTERS\/Mohammad Ponir Hossain"},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2021\/06\/03\/indias-challenges-with-covid-19-vaccination\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"India&#8217;s challenges with covid-19 vaccination\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/373707d32533c2cbca204980b8cd3493","name":"julietwalker","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34f10b717c81464cc7a2879c84cd30078f63b5a901e12905a02abd9d1ea9ec90?s=96&d=mm&r=g","caption":"julietwalker"},"url":"https:\/\/blogs.bmj.com\/bmj\/author\/julietwalker\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/50376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/66"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=50376"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/50376\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media\/50378"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=50376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=50376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=50376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}